Joshi K - Search Results

1

Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

Pilon D, Sheehan JJ, Szukis H, Morrison L, Zhdanava M, Lefebvre P, Joshi K. Pilon D, et al. Among authors: joshi k. J Affect Disord. 2019 Aug 1;255:50-59. doi: 10.1016/j.jad.2019.04.100. Epub 2019 May 1. J Affect Disord. 2019. PMID: 31128505 Free article.

2

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.

Pilon D, Joshi K, Tandon N, Lafeuille MH, Kamstra RL, Emond B, Lefebvre P. Pilon D, et al. Among authors: joshi k. Patient Prefer Adherence. 2017 Mar 23;11:619-629. doi: 10.2147/PPA.S127623. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28356723 Free PMC article.

3

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia.

Pilon D, Muser E, Lefebvre P, Kamstra R, Emond B, Joshi K. Pilon D, et al. Among authors: joshi k. BMC Psychiatry. 2017 Jun 2;17(1):207. doi: 10.1186/s12888-017-1358-3. BMC Psychiatry. 2017. PMID: 28576133 Free PMC article.

4

Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.

Lefebvre P, Muser E, Joshi K, DerSarkissian M, Bhak RH, Duh MS, Shiner B, Young-Xu Y. Lefebvre P, et al. Among authors: joshi k. Clin Ther. 2017 Jul;39(7):1380-1395.e4. doi: 10.1016/j.clinthera.2017.05.356. Epub 2017 Jun 20. Clin Ther. 2017. PMID: 28641996 Free article.

5

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting.

Joshi K, Lafeuille MH, Brown B, Wynant W, Emond B, Lefebvre P, Tandon N. Joshi K, et al. Curr Med Res Opin. 2017 Oct;33(10):1763-1772. doi: 10.1080/03007995.2017.1359516. Epub 2017 Aug 4. Curr Med Res Opin. 2017. PMID: 28741387

6

Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.

Joshi K, Lafeuille MH, Kamstra R, Tiggelaar S, Lefebvre P, Kim E, Yue Y, Tandon N. Joshi K, et al. J Comp Eff Res. 2018 Feb;7(2):121-133. doi: 10.2217/cer-2017-0043. Epub 2017 Aug 15. J Comp Eff Res. 2018. PMID: 28809128 Free article.

7

Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.

Pilon D, Tandon N, Lafeuille MH, Kamstra R, Emond B, Lefebvre P, Joshi K. Pilon D, et al. Among authors: joshi k. Clin Ther. 2017 Oct;39(10):1972-1985.e2. doi: 10.1016/j.clinthera.2017.08.008. Epub 2017 Sep 15. Clin Ther. 2017. PMID: 28919292 Free article.

8

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics.

Lafeuille MH, Tandon N, Tiggelaar S, Kamstra R, Lefebvre P, Kim E, Yue Y, Joshi K. Lafeuille MH, et al. Among authors: joshi k. Drugs Real World Outcomes. 2018 Mar;5(1):81-90. doi: 10.1007/s40801-018-0130-4. Drugs Real World Outcomes. 2018. PMID: 29363022 Free PMC article.

9

Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics.

Kamstra R, Pilon D, Lefebvre P, Emond B, Joshi K. Kamstra R, et al. Among authors: joshi k. Curr Med Res Opin. 2018 Aug;34(8):1377-1388. doi: 10.1080/03007995.2018.1442822. Epub 2018 Feb 28. Curr Med Res Opin. 2018. PMID: 29452492

10

Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population.

Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Joshi K, et al. J Comp Eff Res. 2018 Aug;7(8):723-735. doi: 10.2217/cer-2018-0003. Epub 2018 May 3. J Comp Eff Res. 2018. PMID: 29722547 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,014 results

Search Page

Filters